BioSpace News Archive

bioAffinity Technologies , a privately held biotech company, today announced Martin Tammemägi , PhD, Professor Emeritus of Health Sciences at Brock University, will serve as Chairman of the bioAffinity Scientific and Medical Advisory (SMA) Board. “Dr. Tammemägi is exceptionally well respected and a leader in cancer epidemiology, lung cancer screening and cancer risk prediction modeling,” bioAffinity President and Chi

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced the assembling of a national network of Direct Store Delivery (“DSD”) Distributors in

TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced the inaugural summit in its new thought leadership series, C3: Conversations on Clinical Content.

The Government of Canada is protecting the health and safety of all Canadians, while moving quickly to have access to a safe and sustainable economic recovery

UCM Digital Health, a provider of telehealth technology and services, announces a fully integrated, end-to-end, web and app-based solution designed to screen for symptoms of COVID-19, and provide access to a team of medical providers for follow-up care where further assessment, testing, diagnosis and treatment can take place

OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, presents two virtual posters of their on-going clinical research at the 16th Annual Meeting of the Oligonucleotide Therapeutics Society on September 27 – 30.

Advanced Instruments—an innovative developer of scientific and analytical instruments and related services for the biotech industry—announced the latest release to its biotech instrument portfolio, the OsmoTECH XT Single-Sample Micro-Osmometer.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today the outcome of the pre-planned interim analysis for the Phase 3 RELIEF study of TNX-102 SL (cyclobenzaprine HCl sublingual tablets) 5.6 mg for the management of fibromyalgia.

Adaptive Switch Laboratories (ASL), a division of Invacare Corporation (“Invacare”)(NYSE: IVC), a leading manufacturer and distributor of medical equipment used in non-acute care settings, has been awarded the Rehabilitation Engineering and Assistive Technology Society of North America (RESNA) Leadership Award.

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with Cullinan Oncology.